A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)

Clinical trial NCT06868628 · RECRUITING

Trial details

NCT number: NCT06868628
Sponsor: Tiziana Life Sciences LTD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple System Atrophy

Start date: 2025-05-19
Primary completion: 2027-04-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.